or Try an Advanced Search...

    Technical Analysis for TRAW - Traws Pharma, Inc.

    Grade Last Price % Change Price Change
    D 0.66 3.13% 0.02
    TRAW closed up 3.13 percent on Tuesday, April 30, 2024, on 12 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 13
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Flat
    Historical TRAW trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Jack-in-the-Box Bearish Bearish Swing Setup 3.13%
    Inside Day Range Contraction 3.13%
    Wide Bands Range Expansion 3.13%
    Oversold Stochastic Weakness 3.13%
    Expansion Breakdown Bearish Swing Setup 6.33%
    Reversal New Lows Setup Bearish Swing Setup 6.33%
    Outside Day Range Expansion 6.33%
    Older End-of-Day Signals for TRAW ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 14 hours ago
    Rose Above 10 DMA about 14 hours ago
    Rose Above Previous Day's High about 15 hours ago
    10 DMA Resistance about 15 hours ago
    Up 3% about 15 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    TRAW Chart by TradingView
    Basic chart:

    Profile

    Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer

    Is TRAW a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 4 Traws Pharma Full Year 2023 Earnings: Beats Expectations
    Apr 2 Onconova slips after all-stock merger with Trawsfynydd
    Apr 2 Traws Pharma Announces New Employee Inducement Grants
    Apr 2 Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company
    Dec 12 Onconova stock falls 10% on preclinical data for lymphoma drug
    Dec 12 Onconova Therapeutics’ Narazaciclib ASH Poster Highlights Activity in Treatment Resistant Mantle Cell Lymphoma
    Dec 8 Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s
    Nov 28 Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
    Nov 16 Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q3 2023 Earnings Call Transcript
    Nov 15 Onconova Therapeutics, Inc. (ONTX) Q3 2023 Earnings Call Transcript
    See more TRAW news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.45
    52 Week Low 0.5509
    Average Volume 145,029
    200-Day Moving Average 0.77
    50-Day Moving Average 0.80
    20-Day Moving Average 0.72
    10-Day Moving Average 0.66
    Average True Range 0.06
    RSI (14) 41.52
    ADX 28.75
    +DI 15.89
    -DI 23.92
    Chandelier Exit (Long, 3 ATRs) 0.87
    Chandelier Exit (Short, 3 ATRs) 0.78
    Upper Bollinger Bands 0.86
    Lower Bollinger Band 0.57
    Percent B (%b) 0.3
    BandWidth 39.75
    MACD Line -0.05
    MACD Signal Line -0.05
    MACD Histogram -0.0062
    Fundamentals Value
    Market Cap 13.86 Million
    Num Shares 21 Million
    EPS -0.96
    Price-to-Earnings (P/E) Ratio -0.69
    Price-to-Sales 64.59
    Price-to-Book 1.01
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.70
    Resistance 3 (R3) 0.70 0.68 0.70
    Resistance 2 (R2) 0.68 0.67 0.69 0.69
    Resistance 1 (R1) 0.67 0.67 0.68 0.67 0.69
    Pivot Point 0.66 0.66 0.66 0.66 0.66
    Support 1 (S1) 0.64 0.65 0.65 0.65 0.63
    Support 2 (S2) 0.63 0.64 0.63 0.63
    Support 3 (S3) 0.62 0.63 0.62
    Support 4 (S4) 0.62